No OS Benefit for Adjuvant Treatment of Stage III Melanoma No OS Benefit for Adjuvant Treatment of Stage III Melanoma
Guidelines recommending adjuvant treatment for stage III melanoma should be revisited, say researchers reporting a review of data that found no overall survival benefit.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 13, 2023 Category: Dermatology Tags: Hematology-Oncology News Source Type: news

The Metaverse Is the Dermatologist's Ally The Metaverse Is the Dermatologist's Ally
AI provides significant opportunities for improving telehealth visits, immersive surgical planning, or virtual training using 3D skin models.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 12, 2023 Category: Dermatology Tags: Dermatology News Source Type: news

Study Addresses Psoriasis Pregnancy Outcomes, Fertility Study Addresses Psoriasis Pregnancy Outcomes, Fertility
The study included data on over 63,000 women with psoriasis in a UK database and is believed to be one of the largest studies to investigate fertility and obstetric outcomes in this population.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 12, 2023 Category: Dermatology Tags: Dermatology News Source Type: news

VA Study Finds Lower Racial Disparity in Melanoma Diagnoses VA Study Finds Lower Racial Disparity in Melanoma Diagnoses
The results might be explained by"all patients in the VA dataset having insured access to health care, regardless of socioeconomic status," the authors wrote.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 9, 2023 Category: Dermatology Tags: Dermatology News Source Type: news

EULAR PsA Update Emphasizes Safety, Non-MSK Manifestations EULAR PsA Update Emphasizes Safety, Non-MSK Manifestations
The update builds on 2019 recommendations and incorporates safety concerns about JAK inhibitors, advises on differential drug efficacy across disease manifestations, and eliminates systemic steroids.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 9, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news

Picosecond Lasers Effective for Treating Cosmetic Tattoos Picosecond Lasers Effective for Treating Cosmetic Tattoos
Historically, facial cosmetic tattoos have proven difficult to remove despite advances in laser technology.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 7, 2023 Category: Dermatology Tags: Dermatology News Source Type: news

EULAR SSc Recommendations Now Include Immunosuppressants EULAR SSc Recommendations Now Include Immunosuppressants
The update to 2017 recommendations include targeted synthetic and biologic disease-modifying antirheumatic drugs for the first time.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 5, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news

ILD Risk Elevated in RA, PsA After Starting DMARDs ILD Risk Elevated in RA, PsA After Starting DMARDs
The risk for interstitial lung disease in patients with PsA during the first 5 years was five times higher than for the general population, and the risk was not modified by methotrexate use.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 2, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news

Enthesitis Linked to Dupilumab Use for Atopic Dermatitis Enthesitis Linked to Dupilumab Use for Atopic Dermatitis
Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how enthesitis develops.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 31, 2023 Category: Dermatology Tags: Dermatology News Source Type: news

Severe HCQ Nonadherence Linked to Worse SLE Outcomes Severe HCQ Nonadherence Linked to Worse SLE Outcomes
Severe nonadherence to hydroxychloroquine in patients with lupus is associated with an increased risk of flare, organ damage, and mortality within 5 years, leading experts to advise routine testing.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 26, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news

Amgen Settles Patent Lawsuit Over Biosimilar of Stelara Amgen Settles Patent Lawsuit Over Biosimilar of Stelara
Johnson& Johnson has settled its lawsuit over Amgen ' s proposed biosimilar version of J&J ' s top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 25, 2023 Category: Dermatology Tags: Dermatology News Source Type: news

AMA President on Fighting Prior Auth, Scope Creep, and More AMA President on Fighting Prior Auth, Scope Creep, and More
The president of the American Medical Association, Jack Resneck Jr, MD, discusses government interference in healthcare, the prior authorization mess, and more in a wide-ranging interview with Medscape.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 19, 2023 Category: Dermatology Tags: Family Medicine/Primary Care News Source Type: news

IVIG Shows No Impact on VTE Risk in Dermatomyositis Patients IVIG Shows No Impact on VTE Risk in Dermatomyositis Patients
The rate of venous thromboembolism did not increase in dermatomyositis patients treated with intravenous immunoglobulin, compared with those not treated with IVIG.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 12, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news

Cutaneous Vasculitis Curtails Quality of Life Cutaneous Vasculitis Curtails Quality of Life
Survey respondents described generally poor health-related quality of life (QoF) that was characterized as being more severe with a skin-specific instrument than with a generic health-related QoF index.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 12, 2023 Category: Dermatology Tags: Dermatology News Source Type: news

FDA Clears Renuvion APR Handpiece for Use After Liposuction FDA Clears Renuvion APR Handpiece for Use After Liposuction
The agency ’s update on Wednesday follows three updates on the Renuvion/J-Plasma system in 2022.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 12, 2023 Category: Dermatology Tags: Dermatology News Source Type: news